CSIMarket
 

Precigen Inc   (NASDAQ: PGEN)

Precigen Inc 's

Competitiveness




 

PGEN Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Precigen Inc reported Revenue increase in the 1 quarter 2026 by 1633.93 % year on year.
The sales growth was above Precigen Inc 's competitors' average revenue growth of 8.67 %, achieved in the same quarter.

List of PGEN Competitors





Revenue Growth Comparisons




Net Income Comparison


Precigen Inc , slower than the average decrease reported by the company's competitors of -19.06 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -19.06 %

<<  PGEN Stock Performance Comparisons



  

Overall company Market Share Q1 2026

Due to outstanding performance in Overall company, revenue grew by 1633.93 % Precigen Inc improved its market share, to approximately 0.04 %.




<<  More on PGEN Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Precigen Inc




Tango Therapeutics Inc
Share Performance



-10.90%
30 Days



Tango Therapeutics Inc
Profile

Tango Therapeutics Inc is a biotechnology company that focuses on developing cancer therapies using DNA sequencing and computational biology. Their business model revolves around discovering and developing precision medicines by leveraging their expertise in genomics and biology to target specific cancer vulnerabilities.

More about Tango Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3,502.601 mill. $ - mill. $ -123.720 mill.


Synlogic Inc
Share Performance



+67.12%
This Quarter



Synlogic Inc
Profile

Synlogic Inc's business model revolves around utilizing synthetic biology to develop innovative microbial engineering solutions. They focus on developing Synthetic Biotic medicines, which are living medicines designed to treat diseases by targeting specific metabolic or immuno-inflammatory pathways in the body.

More about Synlogic Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 15.151 mill. $ - mill. $ -0.655 mill.


Xenetic Biosciences Inc
Share Performance



+26.92%
30 Days



Xenetic Biosciences Inc
Profile

Xenetic Biosciences Inc is a biopharmaceutical company that focuses on developing personalized therapeutics with the potential to improve patient outcomes. The company employs a business model centered around leveraging its proprietary drug development platform to partner with pharmaceutical companies and advance novel drug candidates through preclinical and clinical stages.

More about Xenetic Biosciences Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 9.338 mill. $ 3.261 mill. $ -2.475 mill.


Cellectar Biosciences Inc
Share Performance



-5.58%
This Quarter



Cellectar Biosciences Inc
Profile

Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.

More about Cellectar Biosciences Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10.049 mill. $ - mill. $ -20.841 mill.


Cypherpunk Technologies Inc
Share Performance



+30.95%
Over The Past 5 Days



Cypherpunk Technologies Inc
Profile

Cypherpunk Technologies develops privacy technologies and digital asset strategies with a focus on Zcash.

More about Cypherpunk Technologies Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 478.155 mill. $ - mill. $ -0.877 mill.

114 more competitors available

Sign in to see all competitors

Sources: Precigen Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Precigen Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.